SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics Inc. announced today that its ADEXUSDx® product line has been selected as a finalist in the “Testing and Diagnostic Products and Systems” category of the 19th Annual Medical Design Excellence Awards (MDEA) competition. The 2017 winners will be announced at the 2017 MDEA Ceremony on Tuesday, June 13, 2017, in conjunction with the MD&M East event, organized by UBM, taking place at the Jacob K. Javits Convention Center in New York. To learn more about the event please visit: www.MDMeast.com.
The MDEA are the medtech industry’s premier design competition, committed to recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. The awards program celebrates the accomplishments of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives, improving patient healthcare and transforming medtech—one innovation at a time.
“We are honored to be recognized by the MDEA judges,” said Vicki Thompson, Director of Product Development for NOWDiagnostics. “We’re proud to see the innovative design of this platform recognized in this way.”
The 2017 MDEA Juror Panel selected 45 exceptional finalists in nine medical technology product categories. Products were judged based on: design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. Unlike other design competitions that are merely styling contests, the MDEA jury is comprised of a balance of practicing doctors, nurses and technicians alongside industrial designers, engineers, manufacturers and human factors experts.
About NOWDiagnostics, Inc.
NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease the waiting period to determine test results by days. The company’s Springdale, Ark., facility was officially registered with the U.S. Food and Drug Administration in December 2014. The company is currently offering an hCG (pregnancy) test in the United States and Europe as well as three cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases, and a variety of screening tests. For more information about NOWDiagnostics, visit www.nowdx.com.
About Medical Design Excellence Awards
The MDEA program is presented by UBM, the global advanced manufacturing and MedTech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry’s central source for late breaking news, information, and business intelligence. For more information about the Medical Design Excellence Awards—including additional details about the manufacturers and suppliers that created the 2017 MDEA-winning products—visit the MDEA website at www.MDEAwards.com or e-mail: email@example.com.
UBM plc is the largest pure-play B2B Events organizer in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses. Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors – from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions. For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM, UBM Plc LinkedIn.